IEC 81001-5-1 Compliance Software | Medical Device Cybersecurity Lifecycle | Certivo - Certivo
IEC 81001-5-1 Compliance
Cybersecurity & Data Protection Laws
Health Software and Health IT Systems Safety, Effectiveness and Security — Part 5-1: Security — Activities in the Product Life Cycle
FDA and EU Notified Bodies Are Now Rejecting Submissions for Cybersecurity Gaps. Can You Prove Lifecycle Security Across Your Supply Chain?
IEC 81001-5-1 compliance demands structured cybersecurity evidence across the entire health software lifecycle—from threat modeling and secure development through post-market vulnerability management. The FDA recognizes it as a consensus standard. EU Notified Bodies treat it as state of the art under MDR Annex I §17.2. Japan's PMDA has mandated it since April 2024. Compliance requires supplier-level security documentation, SBOM traceability, and continuous compliance monitoring and audit readiness across every software component in your device.
Certivo automates cybersecurity evidence collection from suppliers to audit-ready documentation.
See How Certivo Automates IEC 81001-5-1 Compliance
6
Normative clauses covering the full software lifecycle (Clauses 4–9)
May 2028
EU harmonization deadline under MDR/IVDR
75%+
Of modern medical device software consists of third-party components
Regulation Overview
Jurisdiction
Global (IEC international standard; adopted in EU as EN IEC 81001-5-1:2022, recognized by FDA, mandatory in Japan)
Regulatory Body
International Electrotechnical Commission (IEC), EU Notified Bodies under MDR/IVDR, U.S. FDA, Japan PMDA
Regulation Number
IEC 81001-5-1:2021 (EN IEC 81001-5-1:2022 in EU; Interpretation Sheet ISH1:2025 published)
Effective Date
Published December 2021; EU harmonization scheduled May 27, 2028; FDA consensus standard since 2022; Japan mandatory since April 2024
Official Source
Key Threshold
All health software: SaMD, SiMD, MDSW, and non-medical health software containing cybersecurity risk
What Is IEC 81001-5-1?
IEC 81001-5-1 is the first international cybersecurity standard built specifically for health software, and it is rapidly becoming the cornerstone of medical device cybersecurity compliance globally. For supply chain and compliance teams, the primary obligation is ensuring that every software component—including third-party libraries, open-source dependencies, and supplier-provided modules—meets structured cybersecurity lifecycle requirements from design through decommissioning.
The standard defines process requirements across six normative clauses (Clauses 4–9), covering secure development planning, security risk management aligned with ISO 14971, vulnerability handling, and post-market security maintenance. It supplements IEC 62304 with cybersecurity-specific activities at each software lifecycle phase and requires integration into the Quality Management System under ISO 13485. EU Notified Bodies already treat EN IEC 81001-5-1:2022 as the definitive reference for satisfying MDR Annex I §17.2 cybersecurity requirements, while the FDA's June 2025 final guidance cites it as a recommended framework under Section 524B of the FD&C Act.
IEC 81001-5-1 compliance requires component-level cybersecurity evidence—SBOM data, threat models, and vulnerability assessments—from every supplier contributing software to your device. When new vulnerabilities emerge, your entire portfolio requires reassessment through a centralized compliance data backbone.
Key Components / Sub-Frameworks
Obligation
Establish cybersecurity within ISO 13485 QMS; classify every software item
Clause 4 — General Requirements
QMS integration, security lifecycle categories (Required/Supported/Maintained), and training
Obligation
Threat modeling, secure design review, SAST/DAST, SBOM in SPDX/CycloneDX
Clause 5 — Software Development Process
Secure SDLC from planning through release, including secure coding, architecture review, and SBOM generation
Obligation
Continuous vulnerability monitoring; timely patch delivery; update communication
Clause 6 — Software Maintenance Process
Post-market security updates, vulnerability monitoring, and end-of-support planning
Obligation
Document security context, threat models, and risk control measures
Clause 7 — Security Risk Management
Threat identification, security risk assessment integrated with ISO 14971
Obligation
Maintain SBOM accuracy through every release; track third-party component status
Clause 8 — Software Configuration Management
Traceability of software components, dependency management, and change control
Obligation
Triage, assess, and remediate vulnerabilities with documented timelines
Clause 9 — Software Problem Resolution
Vulnerability handling, incident response, and coordinated vulnerability disclosure
Key Compliance Requirements
Who Must Comply
- Medical device manufacturers developing software-containing or software-driven devices
- Software as a Medical Device (SaMD) developers placing products on EU, U.S., or Japanese markets
- Contract software developers contributing components to regulated medical devices
- Suppliers providing third-party software libraries, SOUP/OTS components, or firmware
- System integrators assembling complex multi-component medical device platforms
- Health software developers building non-device health IT applications in the EU
Key Thresholds
Any software component
All health software subject to IEC 81001-5-1—no safety class exemption unlike IEC 62304
Cyber device classification
FDA: software + internet connectivity capability + susceptibility to cybersecurity threats
May 27, 2028
EU harmonization deadline—full compliance with EN IEC 81001-5-1:2022 expected by Notified Bodies
4–9 months
Typical implementation timeline with mature ISO 13485 QMS and IEC 62304 processes
Core Obligations
Secure Development (Clause 5)Implement threat modeling, secure coding standards, and security V&V including penetration testingDEADLINEPre-market submission; ongoing for updatesSBOM GenerationProvide machine-readable Software Bill of Materials (SPDX/CycloneDX) for all componentsDEADLINERequired at submission; updated with every releaseVulnerability Management (Clause 9)Monitor CVE feeds, triage vulnerabilities, deliver timely patchesDEADLINEContinuous post-market; critical risks addressed within defined timelinesSecurity Risk Management (Clause 7)Integrate security risk assessment with ISO 14971, document threat models and residual riskDEADLINEThroughout product lifecyclePost-Market Surveillance (Clause 6)Monitor for new threats, communicate update responsibilities, maintain incident response processesDEADLINEOngoing until device end-of-life
IEC 81001-5-1 Specific Pain Points
The Multi-Tier SBOM Blind Spot
Your device contains 200+ software components from 15 suppliers across three tiers. The FDA requires a machine-readable SBOM listing every dependency. Supplier 1 delivers a spreadsheet with product names but no version numbers. Supplier 2 provides an outdated SPDX file. Supplier 3 claims their firmware is proprietary and refuses disclosure. Without multi-tier supply chain transparency, your SBOM is incomplete—and the FDA's refuse-to-accept policy activates.
The Post-Market Vulnerability Avalanche
A critical CVE affects an open-source library embedded three tiers deep in your device software. Your security team discovers it from a CVE feed—but tracing which products contain the affected component requires manually cross-referencing supplier documentation across dozens of declarations. By the time you identify exposure, the vulnerability has been public for weeks. Regulatory intelligence and horizon scanning without automation is an exercise in delayed reaction.
The Dual-Jurisdiction Documentation Trap
Your device ships to the EU and U.S. simultaneously. The FDA demands 12 eSTAR cybersecurity documents under Section 524B. EU Notified Bodies expect evidence mapped to all six normative clauses of EN IEC 81001-5-1:2022. Japan's PMDA requires JIS T 81001-5-1 alignment. Each regulator expects slightly different documentation formats, evidence structures, and traceability depths. Without a centralized compliance data backbone, your team produces three parallel documentation sets manually.
The Supplier Security Evidence Gap
IEC 81001-5-1 Clause 5 requires security evidence for every SOUP and OTS component in your device. You need vulnerability assessments, secure coding attestations, and component lifecycle information from each supplier. But 40% of your suppliers have never heard of IEC 81001-5-1. Automated supplier data collection and portals replace months of manual chasing with structured, trackable campaigns that close the evidence gap systematically.
Certivo In Action
Certivo in Action—IEC 81001-5-1 Workflow
GET EVIDENCE IN
Collect Cybersecurity Declarations and SBOM Data from Every Supplier—Without the Chasing
CORA launches targeted campaigns to collect component-level cybersecurity evidence, security attestations, and SBOM data from suppliers across every tier, following up automatically and accepting responses in any format.
- Launch cybersecurity evidence campaigns to hundreds of suppliers with one click
- CORA-powered outreach in suppliers' native languages
- Accept any format: SPDX, CycloneDX, Excel, PDF attestations, freeform responses
- Track response rates and escalate non-responders automatically
MAKE SENSE OF IT
Know Instantly Which Components Carry Cybersecurity Risk
CORA extracts every software component to version and dependency level, validates against known vulnerability databases, and flags security gaps through AI document parsing and certificate validation.
- CORA parses supplier declarations to extract component names, versions, and dependency chains
- Automatic validation against CVE databases and known vulnerability feeds
- Real-time alerts when new CVEs affect components in your portfolio
- BOM-level compliance intelligence mapping components to device-level exposure
⚠️
PROVE COMPLIANCE OUT
Generate Audit-Ready Cybersecurity Documentation in Hours, Not Months
Produce regulator-specific evidence packages—FDA eSTAR sections, EU MDR technical file documentation, and PMDA-aligned reports—instantly from validated supplier data.
- One-click cybersecurity evidence packages aligned to FDA Section 524B, MDR, and PMDA requirements
- Pre-formatted SBOM exports in SPDX and CycloneDX for regulatory submission
- Customer-specific templates with full traceability from supplier declaration to regulatory output
- Complete audit trail for every validation, risk assessment, and evidence chain
Features Tabs
Declaration Collection
Certivo's automated campaigns achieve 95% response rates vs. 20–30% with manual outreach through centralized supplier self-service portals.
- Targeted campaigns by component type, supplier tier, or risk category
- Multi-language outreach in suppliers' native languages
- Intelligent follow-up sequences adapting to supplier behavior
- Format-agnostic: SPDX, CycloneDX, PDF, Excel, freeform responses
95%
Supplier Response Rate
Component Extraction
Every supplier declaration parsed to component and version level automatically—no manual data entry through AI document parsing and certificate validation.
- Deep extraction of component names, versions, licenses, and dependency chains
- Parses SPDX, CycloneDX, proprietary SBOM formats, and unstructured PDF attestations
- Multi-language document processing
- Anomaly detection for inconsistent or incomplete cybersecurity declarations
99.2%
Extraction Accuracy
Vulnerability Monitoring
Always validated against current vulnerability intelligence—not your last audit cycle, through continuous compliance monitoring and audit readiness.
- Automatic sync with NVD, GitHub Advisory Database, and CISA KEV Catalog
- BOM-level compliance intelligence mapping vulnerabilities to affected products
- Proactive alerts when new CVEs affect components in your portfolio
- Historical tracking of vulnerability status changes and remediation actions
Real-Time
CVE Database Sync
Regulatory Documentation
Generate cybersecurity evidence packages in hours instead of 3–6 months of manual compilation.
- One-click FDA eSTAR cybersecurity sections with full component disclosure
- MDR technical file documentation meeting EN IEC 81001-5-1:2022 requirements
- Supplier evidence chain with complete traceability for specialized substance reporting solutions
- Deadline tracking for vulnerability remediation and regulatory submission timelines
4 hours
To Audit-Ready Package
SBOM Management
Pre-validated SBOM data turns software transparency from burden to digital passport and traceability systems workflow.
- Pre-formatted SBOM exports in SPDX 2.3 and CycloneDX formats
- Component lifecycle tracking: actively maintained, end-of-life, and abandoned status
- Dependency graph visualization for complex multi-component devices
- Supplier risk scoring and due diligence integration for third-party component assessment
Managing IEC 81001-5-1 alongside related frameworks eliminates duplicate supplier requests. Certivo validates one submission against multiple regulatory requirements through BOM substance and threshold management across both material and cybersecurity domains.
Industries Most Impacted
[Medical Devices & Equipment]
Your Pain Point
Complex multi-component devices; suppliers across 3+ tiers; FDA and EU dual submission
[Pharmaceuticals & Biotech]
Your Pain Point
Companion diagnostics with SaMD components; GxP overlap with cybersecurity
[Electronics Manufacturing]
Your Pain Point
Embedded firmware and OTS components in medical-grade electronics; deep dependency chains
[Aerospace & Defense]
Your Pain Point
Dual-use medical and defense software; CMMC overlap; stringent documentation chains
[Industrial Machinery & Heavy Equipment]
Your Pain Point
IEC 62443 crossover for industrial health monitoring equipment; legacy embedded systems
[Semiconductor & High-Tech]
Your Pain Point
Silicon-level firmware security in medical SoCs; supply chain depth exceeding 5 tiers
Return on Investment
80%
Reduction in Documentation Labor
From Manual Evidence Compilation to Exception Management
CORA extracts cybersecurity evidence automatically through AI-native compliance automation. Your regulatory team focuses on risk decisions that need human judgment—not chasing supplier attestations across email threads.
4 Days
To Audit-Ready Package
Cybersecurity Evidence Acceleration
Generate complete, regulator-specific IEC 81001-5-1 evidence packages in days—not the 3–6 months of manual compilation across regulatory intelligence and horizon scanning cycles.
Real-Time
Vulnerability Intelligence
Proactive Cybersecurity Monitoring
When new CVEs emerge, Certivo reassesses your portfolio instantly through BOM-level compliance intelligence. Know which products contain affected components before regulators or customers ask.
Key Statistics
6
Normative clauses validated with automated lifecycle evidence mapping
99.2%
Component extraction accuracy from supplier cybersecurity declarations
95%
Supplier response rate with CORA-powered evidence collection campaigns
Frequently Asked Questions
What products and companies are subject to IEC 81001-5-1 compliance obligations?
Any manufacturer developing health software—including Software as a Medical Device (SaMD), software embedded in medical devices (SiMD), and non-device health IT applications—must comply with IEC 81001-5-1. Unlike IEC 62304, the standard has no safety class exemption: all requirements apply regardless of device risk classification. Suppliers providing third-party software components, open-source libraries, and OTS modules are also within scope, as manufacturers must obtain cybersecurity lifecycle evidence for every component. CORA automates the collection of this supplier-level evidence at scale.
What are the penalties for failing to meet IEC 81001-5-1 requirements?
In the U.S., the FDA can refuse to accept 510(k), PMA, and De Novo submissions that lack required cybersecurity documentation under Section 524B. In the EU, Notified Bodies may withhold CE marking if cybersecurity evidence does not meet the state of the art represented by EN IEC 81001-5-1:2022. Japan's PMDA can reject approval applications that do not demonstrate JIS T 81001-5-1 conformance. Across all jurisdictions, inadequate cybersecurity documentation increasingly results in submission delays, market access denial, and regulatory enforcement actions.
How does Certivo support IEC 81001-5-1 evidence management across the supply chain?
Certivo launches automated campaigns to collect cybersecurity declarations, SBOM data, and security attestations from suppliers across every tier. CORA parses responses in any format—SPDX, CycloneDX, PDF, Excel, or freeform—extracts component-level data, and validates it against vulnerability databases and IEC 81001-5-1 clause requirements. When new CVEs emerge, CORA reassesses affected products and triggers the appropriate documentation workflows automatically through continuous compliance monitoring and audit readiness.
What documentation formats does Certivo accept from suppliers for cybersecurity evidence?
Certivo accepts any format: SPDX SBOM files, CycloneDX exports, PDF cybersecurity attestations, Excel component lists, XML manifests, and freeform supplier responses. CORA extracts component data regardless of format or language through AI document parsing and certificate validation, eliminating the need to standardize supplier inputs before processing. This format-agnostic approach is critical for IEC 81001-5-1 compliance, where software suppliers across global supply chains deliver evidence in vastly different structures.
Does Certivo support IEC 81001-5-1 alongside FDA Section 524B and EU MDR requirements simultaneously?
Yes. Certivo validates supplier cybersecurity evidence against IEC 81001-5-1 clause requirements, FDA Section 524B SBOM and SPDF expectations, and EU MDR Annex I §17.2 cybersecurity GSPR simultaneously. The same supplier submission generates jurisdiction-specific evidence packages—FDA eSTAR sections, MDR technical file documentation, and PMDA-aligned reports—eliminating duplicate collection campaigns and enabling true multi-framework compliance from a single centralized compliance data backbone.